ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients
March 25, 2020Windtree Therapeutics announced it is planning to study its proprietary KL4 surfactant to potentially mitigate the pulmonary effects of severe COVID-19 infection. -
Windtree, Eleison Announce Study Results of Delivering Inhaled Lipid Cisplatin
June 06, 2019Windtree Therapeutics and Eleison Pharmaceuticals jointly announced positive results of the feasibility study using Windtree's proprietary Aerosol Delivery System (ADS) aerosolization technology to deliver Eleison's inhaled lipid cisplatin (ILC).
Pharma Sources Insight January 2025
